| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Q BioMed Inc (OTCQB: QBIO)
QBIO Technical Analysis
5
| As on 9th Jun 2023 QBIO STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.18 & Strong Sell for SHORT-TERM with Stoploss of 0.44 we also expect STOCK to react on Following IMPORTANT LEVELS. |
QBIOSTOCK Price
| Open | 0.01 | Change | Price | % |
| High | 0.01 | 1 Day | 0.00 | 0.00 |
| Low | 0.01 | 1 Week | 0.00 | 0.00 |
| Close | 0.01 | 1 Month | 0.00 | 0.00 |
| Volume | 1024770 | 1 Year | -0.43 | -97.73 |
| 52 Week High 0.60 | 52 Week Low 0.00 | ||||
OTCQB USA Most Active Stocks
| BMIX | 0.01 | % |
| MOBQ | 0.18 | -5.26% |
| FNMA | 0.45 | 0.00% |
| ALPP | 3.56 | -0.80% |
| ALPP | 3.56 | -0.80% |
| SHMP | 0.06 | 0.00% |
| NWBO | 0.73 | 0.00% |
| VPLM | 0.08 | % |
| NLST | 3.72 | -8.60% |
| SRNA | 2.78 | 14.88% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| QBIO Daily Charts |
QBIO Intraday Charts |
Whats New @ Bazaartrend |
QBIO Free Analysis |
|
|
QBIO Important Levels Intraday
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
QBIO Forecast April 2024
| 4th UP Forecast | 0.49 |
| 3rd UP Forecast | 0.34 |
| 2nd UP Forecast | 0.24 |
| 1st UP Forecast | 0.15 |
| 1st DOWN Forecast | -0.13 |
| 2nd DOWN Forecast | -0.22 |
| 3rd DOWN Forecast | -0.32 |
| 4th DOWN Forecast | -0.47 |
QBIO Weekly Forecast
| 4th UP Forecast | 0.63 |
| 3rd UP Forecast | 0.43 |
| 2nd UP Forecast | 0.31 |
| 1st UP Forecast | 0.18 |
| 1st DOWN Forecast | -0.16 |
| 2nd DOWN Forecast | -0.29 |
| 3rd DOWN Forecast | -0.41 |
| 4th DOWN Forecast | -0.61 |
QBIO Forecast2024
| 4th UP Forecast | 1.28 |
| 3rd UP Forecast | 0.87 |
| 2nd UP Forecast | 0.62 |
| 1st UP Forecast | 0.37 |
| 1st DOWN Forecast | -0.35 |
| 2nd DOWN Forecast | -0.6 |
| 3rd DOWN Forecast | -0.85 |
| 4th DOWN Forecast | -1.26 |
Q BioMed Inc ( OTCQB USA Symbol : QBIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
QBIO Business Profile
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89, a radiopharmaceutical therapeutic for the treatment of bone cancer pain therapies; and Metastron, a radiopharmaceutical drug for metastatic cancer bone pain therapy. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B for liver cancer. Q BioMed Inc. has a partnership with Mannin Research for the development of novel Covid-19 therapeutics. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York. Address: 366 Madison Avenue, New York, NY, United States, 10017
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service